UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

14th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics Frankfurt, Germany

Clinical lung cancer, 2003-05, Vol.4 (6), p.333-335

2003

Volltextzugriff (PDF)

2001 Highlights From: 37th Annual American Society of Clinical Oncology Meeting San Francisco, CA May 12–15, 2001

Clinical lung cancer, 2001-05, Vol.2 (4), p.252-257

2001

Volltextzugriff (PDF)

2002 Highlights From: 14th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics; Frankfurt, Germany November 19–22, 2002

Clinical lung cancer, 2003-05, Vol.4 (6), p.333-335

2003

Volltextzugriff (PDF)

2002 Highlights From: 27th Congress of the European Society for Medical Oncology; Nice, France October 18–22, 2002

Clinical lung cancer, 2002-11, Vol.4 (3), p.140-145

2002

Volltextzugriff (PDF)

2002 Highlights From: 27th Congress of the European Society for Medical Oncology; Nice, France October 18–22, 2002

Clinical lung cancer, 2003-01, Vol.4 (4), p.205-209

2003

Volltextzugriff (PDF)

2003 Highlights From: 10th World Conference on Lung Cancer Vancouver, British Columbia, Canada August 10-14, 2003

Clinical lung cancer, 2003-11, Vol.5 (3), p.142-147

2003

Volltextzugriff (PDF)

2003 Highlights From: 39th Annual Meeting of the American Society of Clinical Oncology Chicago, Illinois May 30 to June 3, 2003

Clinical lung cancer, 2003-07, Vol.5 (1), p.13-17

2003

Volltextzugriff (PDF)

2003 Highlights From: XII European Cancer Conference Copenhagen, Denmark September 21-25, 2003

Clinical lung cancer, 2004-01, Vol.5 (4), p.203-208

2004

Volltextzugriff (PDF)

2004 Highlights From: 29th European Society of Medical Oncology Congress Vienna, Austria October 29 through November 2, 2004

Clinical lung cancer, 2005-01, Vol.6 (4), p.209-213

2005

Volltextzugriff (PDF)

2004 Highlights From: 29th European Society of Medical Oncology Congress Vienna, Austria October 29 through November 2, 2004

Clinical lung cancer, 2005-04, Vol.6 (5), p.272-275

2005

Volltextzugriff (PDF)

2004 Highlights From: 40th Annual Meeting of the American Society of Clinical Oncology New Orleans, Louisiana June 2004

Clinical lung cancer, 2004-07, Vol.6 (1), p.11-16

2004

Volltextzugriff (PDF)

2005 Highlights From: 41st Annual Meeting of the American Society of Clinical Oncology Orlando, FL, May 2005

Clinical lung cancer, 2005-07, Vol.7 (1), p.11-16

2005

Volltextzugriff (PDF)

2005 Highlights From: 96th Annual Meeting of AACR Anaheim, CA, April 2005 41st Annual Meeting of ASCO Orlando, FL, May 2005

Clinical lung cancer, 2005-05, Vol.6 (6), p.333-337

2005

Volltextzugriff (PDF)

Absolute Quantification of All Identified Plasma Proteins from SWATH Data for Biomarker Discovery

Proteomics (Weinheim), 2019-02, Vol.19 (3), p.e1800135-n/a

2019

Volltextzugriff (PDF)

Abstract 754: The effect of CC chemokine ligand-2 (CCL2/MCP-1) and CC chemokine ligand-5 (CCL5/RANTES) on the pharmacokinetics (PK) and the pharmacodynamics (PD) of pegylated liposomal CKD602 (S-CKD602) in patients with advanced solid tumors

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.754-754

2012

Volltextzugriff (PDF)

ABT-888 (veliparib) in combination with weekly carboplatin and paclitaxel in advanced solid tumors

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.TPS1138-TPS1138

2012

Volltextzugriff (PDF)

Activity of Bortezomib in Advanced Non–Small-Cell Lung Cancer

Clinical lung cancer, 2004-11, Vol.6 (3), p.141-142

2004

Volltextzugriff (PDF)

Activity of Docetaxel in Platinum-Treated Non–Small-Cell Lung Cancer: Results of a Phase II Multicenter Trial

Journal of clinical oncology, 2000-01, Vol.18 (1), p.131-135

2000

Volltextzugriff (PDF)

Activity of ZD1839 (Gefitinib, Iressa™) in Previously Treated Patients with Recurrent and Advanced non—small-Cell Lung Cancer

Clinical lung cancer, 2002-07, Vol.4 (1), p.23-25

2002

Volltextzugriff (PDF)

Adjuvant and neoadjuvant therapy in non-small cell lung cancer: Selected Proceedings from the Chemotherapy Foundation Symposium, Innovative Cancer Therapy for Tomorrow

Seminars in oncology, 2005, Vol.32 (2), p.9-15

BELANI, Chandra P

2005

Volltextzugriff (PDF)

Adjuvant and neoadjuvant therapy in non-small cell lung cancer

Seminars in oncology, 2005-04, Vol.32 (2 Suppl 2), p.S9-S15

Belani, Chandra P.

2005

Volltextzugriff (PDF)

Adjuvant therapy for surgically resected non-small-cell lung cancer: will it become a reality?

Clinical lung cancer, 2003-01, Vol.4 (4), p.203-204

Belani, Chandra P

2003

Volltextzugriff (PDF)

Advanced NSCLC patients with high IL-6 levels have altered peripheral T cell population and signaling

Lung cancer (Amsterdam, Netherlands), 2019-05, Vol.131, p.58-61

2019

Volltextzugriff (PDF)

Afatinib for the treatment of metastatic non-small cell lung cancer

Cancer management and research, 2015-01, Vol.7 (default), p.75-82

2015

Volltextzugriff (PDF)

The ANITA trial seals the deal for adjuvant therapy in non-small-cell lung cancer

Clinical lung cancer, 2005-05, Vol.6 (6), p.331-332

Belani, Chandra P

2005

Volltextzugriff (PDF)

1 – 25 von 358

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(346)
Mit Volltextzugriff
(327)

Publikationsform

Sprache

Englisch
(358)

Erscheinungsjahr

n.n

Thema

Humans
(227)
Science & Technology
(205)
Life Sciences & Biomedicine
(201)
Oncology
(162)
Lung Neoplasms - Drug Therapy
(123)
Female
(117)
Male
(114)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(110)
Middle Aged
(109)
Aged
(103)
Biological And Medical Sciences
(90)
Medical Sciences
(90)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(82)
Lung Neoplasms - Pathology
(71)
Adult
(70)
Treatment Outcome
(67)
Carcinoma, Non-Small-Cell Lung - Pathology
(50)
Respiratory System
(50)
Aged, 80 And Over
(49)
Lung Neoplasms - Mortality
(45)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

14th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics Frankfurt, Germany

2001 Highlights From: 37th Annual American Society of Clinical Oncology Meeting San Francisco, CA May 12–15, 2001

2002 Highlights From: 14th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics; Frankfurt, Germany November 19–22, 2002

2002 Highlights From: 27th Congress of the European Society for Medical Oncology; Nice, France October 18–22, 2002

2002 Highlights From: 27th Congress of the European Society for Medical Oncology; Nice, France October 18–22, 2002

2003 Highlights From: 10th World Conference on Lung Cancer Vancouver, British Columbia, Canada August 10-14, 2003

2003 Highlights From: 39th Annual Meeting of the American Society of Clinical Oncology Chicago, Illinois May 30 to June 3, 2003

2003 Highlights From: XII European Cancer Conference Copenhagen, Denmark September 21-25, 2003

2004 Highlights From: 29th European Society of Medical Oncology Congress Vienna, Austria October 29 through November 2, 2004

2004 Highlights From: 29th European Society of Medical Oncology Congress Vienna, Austria October 29 through November 2, 2004

2004 Highlights From: 40th Annual Meeting of the American Society of Clinical Oncology New Orleans, Louisiana June 2004

2005 Highlights From: 41st Annual Meeting of the American Society of Clinical Oncology Orlando, FL, May 2005

2005 Highlights From: 96th Annual Meeting of AACR Anaheim, CA, April 2005 41st Annual Meeting of ASCO Orlando, FL, May 2005

Absolute Quantification of All Identified Plasma Proteins from SWATH Data for Biomarker Discovery

Abstract 754: The effect of CC chemokine ligand-2 (CCL2/MCP-1) and CC chemokine ligand-5 (CCL5/RANTES) on the pharmacokinetics (PK) and the pharmacodynamics (PD) of pegylated liposomal CKD602 (S-CKD602) in patients with advanced solid tumors

ABT-888 (veliparib) in combination with weekly carboplatin and paclitaxel in advanced solid tumors

Activity of Bortezomib in Advanced Non–Small-Cell Lung Cancer

Activity of Docetaxel in Platinum-Treated Non–Small-Cell Lung Cancer: Results of a Phase II Multicenter Trial

Activity of ZD1839 (Gefitinib, Iressa™) in Previously Treated Patients with Recurrent and Advanced non—small-Cell Lung Cancer

Adjuvant and neoadjuvant therapy in non-small cell lung cancer: Selected Proceedings from the Chemotherapy Foundation Symposium, Innovative Cancer Therapy for Tomorrow

Adjuvant and neoadjuvant therapy in non-small cell lung cancer

Adjuvant therapy for surgically resected non-small-cell lung cancer: will it become a reality?

Advanced NSCLC patients with high IL-6 levels have altered peripheral T cell population and signaling

Afatinib for the treatment of metastatic non-small cell lung cancer

The ANITA trial seals the deal for adjuvant therapy in non-small-cell lung cancer

Suchergebnisse filtern